|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2010-11-5
|
|
pubmed:abstractText |
Mirodenafil is a recently developed oral phosphodiesterase type 5 inhibitor, which was observed to significantly improve erectile function and was well tolerated in men with broad-spectrum erectile dysfunction (ED).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1743-6109
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
© 2010 International Society for Sexual Medicine.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
7
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3143-52
|
|
pubmed:meshHeading |
pubmed-meshheading:20649936-Antihypertensive Agents,
pubmed-meshheading:20649936-Blood Pressure,
pubmed-meshheading:20649936-Double-Blind Method,
pubmed-meshheading:20649936-Electrocardiography,
pubmed-meshheading:20649936-Erectile Dysfunction,
pubmed-meshheading:20649936-Flushing,
pubmed-meshheading:20649936-Headache,
pubmed-meshheading:20649936-Heart Rate,
pubmed-meshheading:20649936-Humans,
pubmed-meshheading:20649936-Hypertension,
pubmed-meshheading:20649936-Male,
pubmed-meshheading:20649936-Middle Aged,
pubmed-meshheading:20649936-Phosphodiesterase 5 Inhibitors,
pubmed-meshheading:20649936-Pyrimidinones,
pubmed-meshheading:20649936-Sulfonamides
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Efficacy and safety of mirodenafil in men taking antihypertensive medications.
|
|
pubmed:affiliation |
Department of Urology, Seoul National University Hospital, Seoul, Korea. jspaick@snu.ac.kr
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Multicenter Study
|
